System Suitability Tests (SST) in Potency Assays: SOP Key Steps

In the realm of biopharmaceutical development, the validity of your potency data hinges on one fundamental pillar: the performance of the analytical system at the moment of testing. Unlike simple analytical methods, potency assays are susceptible to significant biological variability, stemming from cell culture health, reagent stability, and environmental fluctuations. This is where System Suitability Tests (SST) become the heartbeat of laboratory quality control.

SSTs are pre-defined criteria that ensure the analytical system—including the instrumentation, the biological reagents, and the data processing software—is functioning within an acceptable, "controlled" state before sample results are accepted. This Standard Operating Procedure (SOP) outlines the critical framework for implementing rigorous SSTs to ensure your potency data stands up to the highest regulatory scrutiny.

1. Defining the Controlled State: The Purpose of SST

The goal of an SST is to confirm that the assay is "fit for purpose" for every single run. It acts as a gatekeeper; if the SST criteria are not met, the entire run must be invalidated, regardless of the test sample results. This protects the integrity of your clinical data and ensures that inter-run variability is minimized.

For those looking to streamline these complex quality control requirements, Alfa Chemistry provides specialized potency testing services. Our laboratories utilize pre-validated SOPs that incorporate stringent SST protocols, ensuring that your projects benefit from industry-leading data reliability and adherence to global regulatory guidelines.

2. Critical Parameters for SST Execution

To establish a robust control system, your SOP must define specific quantitative thresholds for the following parameters:

• Reference Standard Recovery: This is the most crucial metric. The potency of your reference standard must fall within a pre-defined acceptance range (e.g., 80% to 120%). If the reference standard performs outside this window, the entire assay is deemed unstable.
• Intra-Plate Variability (CV%): Plate-to-plate and well-to-well variations must be strictly monitored. Calculating the Coefficient of Variation (CV) for replicates ensures that your pipetting and cell distribution techniques are consistent. A typical acceptance criterion for cell-based assays is a CV < 15-20%.
• Parallelism: The dose-response curve of the reference standard must remain parallel to historical data. Any significant shift or change in the slope of the curve is a red flag indicating a systemic issue, such as expired reagents or cell drift.
• Signal-to-Noise Ratio (S/N): For assays measuring a specific response, the window between the maximum signal (upper asymptote) and the background signal (lower asymptote) must be large enough to distinguish true drug activity from assay noise.

3. Procedural SOP for System Suitability

To ensure compliance, follow these sequential steps in your laboratory workflow:

1) Pre-Run Verification: Confirm all instruments (e.g., microplate readers, incubators) are calibrated and within their maintenance window.
2) Standard and Sample Preparation: Prepare your reference standards and samples in the exact same matrix to minimize matrix interference.
3) Real-Time Data Monitoring: As the plate is being read, perform an immediate check of the raw data. If the plate borders show abnormal values (the "edge effect"), the assay should be flagged for potential bias.
4) Acceptance Review: Before data processing, the lead scientist must verify that the SST metrics (Recovery, CV, S/N) meet the predefined acceptance criteria listed in the protocol.
5) Documentation: All SST results must be permanently attached to the raw data file, ensuring complete audit trails as required by FDA and EMA standards.

4. Handling SST Failures: A Regulatory Necessity

What happens when an SST fails? Your SOP must define the Out-of-Specification (OOS) investigation process.

• Invalidation: Do not report or process sample data if the system fails suitability.
• Root Cause Analysis: Investigate potential sources—cell passage history, incubator fluctuations, or reagent degradation.
• Documentation: All failures must be documented in the lab notebook with an explanation and sign-off by the Quality Assurance (QA) unit.

5. Conclusion

System Suitability Tests are not merely a compliance burden; they are your strongest defense against the high costs of re-testing and the risks of data rejection by regulatory authorities. By standardizing your SSTs, you transform your laboratory into a high-precision facility capable of producing robust, reproducible results that support successful IND and BLA applications.

Frequently Asked Questions (FAQ)